MPM BioImpact LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001687078

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 32 positions · Total reported value $427.43M · Top-10 concentration 60.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 81.2% · 7 new · 21 cut · 11 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +31.4% · vs SPY +16.6% · Prev Value $1.29B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2023 13F filing, MPM BioImpact LLC disclosed 32 equity positions with a combined reported value of $427.43M. The filing implies a focused portfolio: its ten largest positions account for 60.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were CGEM ($77.94M), IOVA ($26.74M), OLMA ($26.06M). By sector, the heaviest allocations are Health Care 70.5%, Materials 0.9%. Versus the prior quarter, allocation shifted toward Health Care (+1.2pp) and away from Other (-1.0pp).

Versus the prior quarter, MPM BioImpact LLC opened 7 new positions, trimmed 21 and fully exited 11, a turnover rate of 81.2% of positions. The portfolio's overlap with the prior quarter was 88% of names.

The largest new positions opened in Q4 2023 were ALXO ($18.83M), IRON ($2.89M).

Of the 11 positions fully exited versus the prior quarter, the largest were KALV ($5.57M), TVTX ($4.94M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • ALXO ALX ONCOLOGY HLDGS INC · $18.83M
  • IRON DISC MEDICINE INC · $2.89M

Fully Exited (vs previous quarter)

  • KALV KALVISTA PHARMACEUTICALS INC · prev qtr: $5.57M
  • TVTX TRAVERE THERAPEUTICS INC · prev qtr: $4.94M · history

Insider Transactions (Form 4)

Latest MPM BioImpact LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

MPM BioImpact LLC, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 37 positions worth $1.64B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-106989 (status: Approved), registered 2016-01-04
  • Regulatory AUM (Form ADV): $3.56B as of 2026-04-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 14 private funds, of which 3 hedge funds

Portfolio Structure

  • 37 positions · $1.64B reported value (Q2 2026)
  • Top 10 holdings = 55.3% of reported value
  • Largest position: CGEM (CULLINAN THERAPEUTICS INC) at 10.8%
  • Average position size: $44.32M

Sector Tilt

  • Health Care 98.7%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 7 new, 7 added, 21 reduced, 11 exited
  • 2 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 70.5%
Materials 0.9%
Other 28.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 7.65M $77.94M 18.23%
18.23%
Hold
2 3.29M $26.74M 6.26%
6.26%
Hold
3 1.86M $26.06M 6.10%
6.10%
Hold
4 10.72M $22.61M 5.29%
5.29%
Hold
5 1.75M $19.12M 4.47%
4.47%
Hold
6 1.26M $18.83M 4.41%
4.41%
New
7 294.58K $17.79M 4.16%
4.16%
Hold
8 478.23K $17.02M 3.98%
3.98%
Hold
9 53.28K $16.86M 3.94%
3.94%
Hold
10 528.15K $16.37M 3.83%
3.83%
Hold
11 611.18K $14.44M 3.38%
3.38%
Hold
12 1.64M $11.97M 2.80%
2.80%
Hold
13 382.60K $11.67M 2.73%
2.73%
Reduce
14 715.88K $10.16M 2.38%
2.38%
Hold
15 549.08K $9.86M 2.31%
2.31%
Reduce
16 40.91K $9.47M 2.21%
2.21%
Hold
17 230.70K $9.40M 2.20%
2.20%
Hold
18 664.99K $9.39M 2.20%
2.20%
Hold
19 323.74K $9.35M 2.19%
2.19%
Add
20 2.39M $9.22M 2.16%
2.16%
Hold
21 832.02K $9.16M 2.14%
2.14%
Reduce
22 3.85M $9.04M 2.12%
2.12%
Reduce
23 638.16K $8.90M 2.08%
2.08%
Reduce
24 273.41K $7.84M 1.83%
1.83%
Hold
25 93.39K $7.43M 1.74%
1.74%
Hold
26 325.28K $6.05M 1.42%
1.42%
Hold
27 5.10M $4.04M 0.94%
0.94%
Hold
28 319.67K $3.63M 0.85%
0.85%
Hold
29 50.00K $2.89M 0.68%
0.68%
New
30 100.00K $2.18M 0.51%
0.51%
Reduce
31 323.81K $1.38M 0.32%
0.32%
Reduce
32 70.00K $639.10K 0.15%
0.15%
Reduce

FAQ

What did MPM BioImpact LLC buy in 2023-Q4?

In its 2023-Q4 13F filing, MPM BioImpact LLC reported 32 equity positions worth $427.43M in aggregate; its largest disclosed positions were CGEM ($77.94M), IOVA ($26.74M), OLMA ($26.06M).

How large is MPM BioImpact LLC's portfolio?

MPM BioImpact LLC reported $427.43M of long equity holdings across 32 positions as of 2023-Q4. Top-10 holdings account for 60.7% of reported value.

What is MPM BioImpact LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/mpm-bioimpact/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →